EP300 and Miyoshi myopathy: In agreement with this notion, combined inhibition of P300/CBP KAT and Bromodomain modules in MM was shown to additively promote histone hypoacetylation, though these effects were less pronounced than a dual P300/CBP-targeting proteolysis-targeting chimera (PROTAC) molecule, dCBP-1, which additionally reduced chromatin accessibility [42].